Compass Therapeutics CMPX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 3.50 | 110.93 | -0.08 | -15,817 | -14 | |
| 2025Q2 | 2.60 | 105.96 | -0.14 | -21,066 | -20 | |
| 2025Q1 | 1.90 | 108.01 | -0.12 | -17,966 | -17 | |
| 2024Q4 | 1.45 | 110.25 | -0.11 | -16,574 | -15 | |
| 2024Q3 | 1.84 | 116.78 | -0.08 | -12,237 | -10 | |
| 2024Q2 | 1.00 | 115.05 | -0.09 | -15,044 | -13 | |
| 2024Q1 | 1.98 | 118.38 | -0.08 | -12,770 | -11 | |
| 2023Q4 | 1.56 | 114.74 | -0.10 | -15,393 | -13 | |
| 2023Q3 | 1.97 | 119.68 | -0.08 | -11,925 | -10 | |
| 2023Q2 | 3.18 | 118.23 | -0.09 | -13,334 | -11 | |
| 2023Q1 | 3.27 | 123.91 | -0.06 | -9,711 | -8 | |
| 2022Q4 | 5.03 | 111.16 | -0.10 | -12,888 | -12 | |
| 2022Q3 | 2.28 | 105.20 | -0.11 | -12,598 | -12 | |
| 2022Q2 | 2.65 | 105.80 | -0.09 | -8,987 | -8 | |
| 2022Q1 | 1.37 | 100.28 | -0.07 | -7,182 | -7 | |
| 2021Q4 | 3.17 | 100.05 | -0.05 | -13,001 | -13 | |
| 2021Q3 | 3.41 | 97.98 | -0.03 | -5,856 | -6 | |
| 2021Q2 | 4.75 | 99.82 | -1.09 | -55,686 | -56 | |
| 2021Q1 | 98.88 | -0.14 | -7,339 | -7 | ||
| 2020Q4 | 106.24 | -0.08 | -7,950 | -8 |